Rat brain monoamines after acute and chronic myo-inositol treatment

European Neuropsychopharmacology

Volumn 10, Issue 1, 1999, Pages 27-30

  Einat, H ^a   Belmaker, R H ^a   Kopilov, M ^a   Klein, E ^b   Gazawi, H ^b   Ben Shachar, D ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Anxiety; Depression; HPLC; Inositol; Monoamines

Indexed keywords

INOSITOL; MONOAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONOAMINE METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; FRONTAL LOBE; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAPERITONEAL; INOSITOL; MALE; MESENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0032714624     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00047-4     Document Type: Article

References (20)

1. Baker P.C., Hoff K.M. Chronic citalopram action and the maturing mouse brain's indoleamine levels. Gen. Pharmacol. 2:1990;703-707.
2. Ben-Shachar D., Belmaker R.H., Grissaru N., Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J. Neural Trans. 104:1997;191-197.
3. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature (London). 361:1993;315-325.
4. Delini-Stula A. New pharmacological findings in depression. Psychopharmacol. 19:(Suppl.):1986;94-102.
5. 2 receptors, in press.
6. Einat, H. Belmaker, R.H. The effects of inositol treatment in animal models of psychiatric disorders. J. Affect. Disord., in press.
7. Einat H., Karbovski H., Korik J., Tsalah D., Belmaker R.H. Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacol. 144:(2):1999.
8. Einat H., Elkabaz-Swartz Z., Cohen H., Kofman O., Belmaker R.H. Chronic myo- and epi-inositol are anxiolytic in the plus-maze model in rats. Int. J. Neuropsychopharmacol. 1:1998;31-34.
9. Hall L.M., Anderson G.M., Cohen D.J. Acute and chronic effects of fluoxetine and haloperidol on mouse serotonin and norepinephrine turnover. Life Sci. 57:1995;791-801.
10. Kofman O., Agam G., Shapiro J., Spencer A. Chronic dietery inositol enhances locomotor activity and brain inositol levels in rats. Psychopharmacol. 139:1998;239-242.
11. Levine J. Controlled trials of inositol in psychiatry. Eur. Neuropsychopharmacol. 7:1997;147-155.
12. Levine J., Mishori A., Susnosky M., Martin M., Belmaker R.H. Combination of inositol and serotonin reuptake inhibitors in the treatment of depression. Biol. Psychiat. 45:1999;270-273.
13. Michell R.H. The multiplying roles of inositol lipids and phosphates in cell control processes. Ess. Biochem. 32:1997;31-47.
14. Millan M.J., Newman-Tancredi A., Rivet J.M., Brocco M., Lacroix P., Audinot V., Cistarelli L., Gobert A. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and alpha 2A adrenergic receptors in relation to modilation of cortical monoamine release and activity in models of potential antidepressant activity. J. Pharmacol. Exper. Therap. 282:1997;132-147.
15. Patishi Y., Lubrich B., Berger M., van Calker D., Kofman O., Belmaker R.H. Differential uptake of myo-inositol in vivo into rat brain areas. Eur. Neuropsychopharmacol. 6:1996;73-76.
16. Peat M.A., Warren P.F., Gibb J.W. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain. J. Pharmacol. Exp. Ther. 225:1983;126-131.
17. Potter W.Z., Rudorfer M.V., Manji H. The pharmacologic treatment of depression. New Eng. J. Med. 325:1991;633-642.
18. Sarkissian C.F., Wurtman R.J., Morse A.N., Gleason R. Effects of fluoexetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex. Brain Res. 529:1990;294-301.
19. Willner P. Antidepressants and serotonergic neurotransmission: An integrative review. Psychopharmacol. 85:1985;387-404.
20. Zangan A., Overstreet D.H., Yadid G. High serotonin and S-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: Normalization by chronic antidepressant treatment. J. Neurochem. 69:1997;2477-2483.